Purchases and Sales Made in Q4 2022 in Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE) during Q4 2022. The information is specifically focused on institutions that hold shares of Monte Rosa Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-24.7K- 59.29% |
$166K - $240K
|
16.9K
$103K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-27.2K- 25.56% |
$182K - $264K
|
79.1K
$480K
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-80K- 2.12% |
$537K - $777K
|
3.68M
$22.3M
|
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-90.1K- 76.7% |
$604K - $876K
|
27.4K
$166K
|
|
|
Feb 14, 2023
Q4 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-100K- 3.34% |
$671K - $972K
|
2.89M
$17.5M
|